基本信息:
- 专利标题： ANTIBODY FORMULATION
- 申请号：PCT/EP2019/080445 申请日：2019-11-06
- 公开(公告)号：WO2020094744A1 公开(公告)日：2020-05-14
- 发明人： ALTINTAS, Isil , SATIJN, David , RADEMAKER, Rik , PARREN, Paul , SAHIN, Ugur , GIESEKE, Friederikke , MUIK, Alexander
- 申请人： GENMAB A/S , BIONTECH SE
- 申请人地址： Kalvebod Brygge 43 1560 Copenhagen V DK
- 专利权人： GENMAB A/S,BIONTECH SE
- 当前专利权人： GENMAB A/S,BIONTECH SE
- 当前专利权人地址： Kalvebod Brygge 43 1560 Copenhagen V DK
- 代理机构： GENMAB A/S
- 优先权： EPPCT/EP2018/080369 20181106
- 主分类号： C07K16/10
- IPC分类号： C07K16/10 ; C07K16/28 ; A61K39/395 ; A61P35/00 ; A61K39/00
摘要：
The present invention relates to pharmaceutical formulations of binding agents and their use in medicine. In particular, the invention relates to pharmaceutical formulations of binding agents such as bispecific antibodies binding human PD-L1 and binding human CD137. The invention furthermore relates to uses of the pharmaceutical formulations of the invention and to methods for producing pharmaceutical formulations.